H. Con Res. 85 and S. Con Res. 13, setting forth the congressional budget for the U.S. Government for FY 2010, issues related to the taxation of foreign earnings of U.S. multinational corporations. S. 515 / S. 610 / H.R. 1260 Patent Reform Act of 2009, all issues related to patent reform. Medicare and Medicaid reimbursement issues for certain drugs and biologicals; all issues related to Medicare coverage of pre-ESRD education.  S. 701,  Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services. H.R. 1765, as it relates to Medicare coverage and payment for IVIG administered in the home. H. Con Res. 85 / S. Con Res. 13, as it relates to health care reform, including comparative effectiveness research and reimbursement for drugs and biologicals under Medicaid. Health care reform legislation as it relates to comparative effectiveness research & reimbursement for drugs and biologicals under Medicaid. S. 525, S. 1232 / H.R. 1298, the Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. Medicare and Medicaid reimbursement issues for certain drugs and biologicals; all issues related to Medicare coverage of pre-ESRD education.  S. 701,  Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services. H.R. 1765, as it relates to Medicare coverage & payment for IVIG administered in the home. H. Con Res. 85 / S. Con Res. 13, as it relates to health care reform, including comparative effectiveness research and reimbursement for drugs and biologicals under Medicaid. Health care reform legislation as it relates to comparative effectiveness research & reimbursement for drugs and biologicals under Medicaid. H. Con Res. 85 and S. Con Res. 13, setting forth the congressional budget for the U.S. Government for FY 2010, issues related to the taxation of foreign earnings of U.S. multinational corporations and issues related to health care reform, including comparative effectiveness research and reimbursement for drugs and biologicals under Medicaid.
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
RACHEL JONES HENSLER (U.S. Senate Budget Committee, Tax Policy Director) CYNTHIA MERIFIELD TRIPODI (U.S. Senator Don Nickles, Legislative Assistant) JEFF MURRAY (U.S. House of Reps., Judiciary Comm., Intern) DOUG BADGER (Deputy Assistant to the President for Leg. Affairs) MARY BETH SAVARY TAYLOR (Joint Economic Committee, General Counsel) DOUG BADGER (Deputy Assistant to the President for Leg. Affairs) MARY BETH SAVARY TAYLOR (Joint Economic Committee, General Counsel) RACHEL JONES HENSLER (U.S. Senate Budget Committee, Tax Policy Director)
U.S. Senate Budget Committee, Tax Policy Director U.S. Senator Don Nickles, Legislative Assistant U.S. House of Reps., Judiciary Comm., Intern Deputy Assistant to the President for Leg. Affairs Joint Economic Committee, General Counsel Deputy Assistant to the President for Leg. Affairs Joint Economic Committee, General Counsel U.S. Senate Budget Committee, Tax Policy Director